Total Payments
$2,606
2024 Payments
$979.66
Companies
19
Transactions
137
Medicare Patients
2,896
Medicare Billing
$224,383
Payment Breakdown by Category
Food & Beverage$2,567 (98.5%)
Education$39.24 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,567 | 136 | 98.5% |
| Education | $39.24 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $914.73 | 55 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $268.80 | 10 | $0 (2024) |
| Daiichi Sankyo Inc. | $250.84 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $240.71 | 6 | $0 (2024) |
| Lilly USA, LLC | $181.11 | 9 | $0 (2024) |
| Axsome Therapeutics, Inc. | $113.28 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $96.42 | 5 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $95.61 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $77.63 | 4 | $0 (2023) |
| Novo Nordisk Inc | $73.25 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $979.66 | 51 | ABBVIE INC. ($488.16) |
| 2023 | $998.17 | 52 | GlaxoSmithKline, LLC. ($196.65) |
| 2022 | $601.40 | 33 | ABBVIE INC. ($242.19) |
| 2018 | $26.88 | 1 | Astellas Pharma US Inc ($26.88) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Respiratory | ||||||
| 08/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.64 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 999 | 1,426 | $216,471 | $80,527 |
| 2022 | 13 | 701 | 1,032 | $194,317 | $72,273 |
| 2021 | 10 | 611 | 744 | $121,369 | $30,339 |
| 2020 | 10 | 585 | 726 | $115,031 | $41,245 |
Total Patients
2,896
Total Services
3,928
Medicare Billing
$224,383
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 134 | 249 | $63,993 | $21,486 | 33.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 113 | 113 | $29,719 | $14,288 | 48.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 123 | 254 | $38,100 | $12,343 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 142 | 182 | $33,124 | $11,623 | 35.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 70 | 70 | $7,000 | $5,307 | 75.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 45 | $16,245 | $5,163 | 31.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 61 | 111 | $12,543 | $4,094 | 32.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 71 | 71 | $4,615 | $2,141 | 46.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 118 | 185 | $2,775 | $1,546 | 55.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 15 | 16 | $1,920 | $757.82 | 39.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 20 | 21 | $3,135 | $593.46 | 18.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 12 | 12 | $696.00 | $415.44 | 59.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 26 | 37 | $888.00 | $352.24 | 39.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 31 | $899.00 | $281.75 | 31.3% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 16 | 18 | $720.00 | $101.88 | 14.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 11 | $99.00 | $34.40 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 169 | 375 | $95,170 | $34,553 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 130 | 191 | $34,602 | $12,531 | 36.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 85 | 85 | $22,143 | $10,621 | 48.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 35 | 42 | $15,021 | $5,741 | 38.2% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 14 | 16 | $6,608 | $2,649 | 40.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $9,990 | $2,518 | 25.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 18 | 25 | $2,650 | $1,061 | 40.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 14 | 15 | $1,800 | $708.58 | 39.4% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 14 | 14 | $1,805 | $512.91 | 28.4% |
About Dr. Steven Cutone, D.O
Dr. Steven Cutone, D.O is a Internal Medicine healthcare provider based in Biddeford, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831152743.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Cutone, D.O has received a total of $2,606 in payments from pharmaceutical and medical device companies, with $979.66 received in 2024. These payments were reported across 137 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,567).
As a Medicare-enrolled provider, Cutone has provided services to 2,896 Medicare beneficiaries, totaling 3,928 services with total Medicare billing of $224,383. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Biddeford, ME
- Active Since 04/11/2006
- Last Updated 09/13/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1831152743
Products in Payments
- UBRELVY (Drug) $486.75
- INJECTAFER (Drug) $250.84
- VRAYLAR (Drug) $245.37
- QULIPTA (Drug) $156.88
- FARXIGA (Drug) $152.96
- AREXVY (Drug) $149.44
- MOUNJARO (Drug) $138.68
- AIRSUPRA (Drug) $115.84
- Auvelity (Drug) $113.28
- Kerendia (Drug) $95.61
- ENTRESTO (Drug) $76.42
- TRELEGY ELLIPTA (Drug) $75.57
- FREESTYLE LIBRE 3 (Device) $57.96
- PAXLOVID (Drug) $57.88
- Ozempic (Drug) $57.52
- JARDIANCE (Drug) $53.33
- ELIQUIS (Drug) $39.07
- XARELTO (Drug) $28.00
- MYRBETRIQ (Drug) $26.88
- TEFLARO (Drug) $25.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Biddeford
Dr. Peter Rubin, M.d, M.D
Internal Medicine — Payments: $31,481
Internal Medicine $31,481
Yasmin Mahal, Do, DO
Internal Medicine — Payments: $2,642
Internal Medicine $2,642
Jennifer Cutone, M.d, M.D
Internal Medicine — Payments: $2,262
Internal Medicine $2,262
Dr. Mahesh Bandara, M.d, M.D
Internal Medicine — Payments: $1,733
Internal Medicine $1,733
Dr. Woodrow Lee, Do, DO
Internal Medicine — Payments: $1,712
Internal Medicine $1,712
Dr. Maureen Lee, D.o, D.O
Internal Medicine — Payments: $1,636
Internal Medicine $1,636